Form 8-K - Current report:
SEC Accession No. 0001558370-20-014190
Filing Date
2020-12-04
Accepted
2020-12-04 16:54:17
Documents
13
Period of Report
2020-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axgn-20201130x8k.htm   iXBRL 8-K 39724
2 EX-10.9.5 axgn-20201130xex10d9d5.htm EX-10.9.5 27893
  Complete submission text file 0001558370-20-014190.txt   182562

Data Files

Seq Description Document Type Size
3 EX-101.SCH axgn-20201130.xsd EX-101.SCH 3028
4 EX-101.LAB axgn-20201130_lab.xml EX-101.LAB 14241
5 EX-101.PRE axgn-20201130_pre.xml EX-101.PRE 9274
6 EXTRACTED XBRL INSTANCE DOCUMENT axgn-20201130x8k_htm.xml XML 4351
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36046 | Film No.: 201370450
SIC: 3845 Electromedical & Electrotherapeutic Apparatus